| Liang R Bartkowiak, MD | |
|
1701 12th Ave, Building A, Altoona, PA 16601-3100 | |
| (814) 944-7097 | |
| (814) 944-5557 |
| Full Name | Liang R Bartkowiak |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 1701 12th Ave, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144221813 | NPI | - | NPPES |
| 0017510490001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD068355L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Altoona | Altoona, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Altoona Ob/gyn Associates Inc | 9133020647 | 5 |
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.
EvaluatePharma USA, Inc. the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Boston's biotech community today by Mayor Menino at the opening of their new office in Boston, the #1 life sciences cluster in the US.
› Verified 1 days ago
| Entity Name | Altoona Ob/gyn Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164449930 PECOS PAC ID: 9133020647 Enrollment ID: O20040117000001 |
News Archive
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.
EvaluatePharma USA, Inc. the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Boston's biotech community today by Mayor Menino at the opening of their new office in Boston, the #1 life sciences cluster in the US.
› Verified 1 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.
EvaluatePharma USA, Inc. the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Boston's biotech community today by Mayor Menino at the opening of their new office in Boston, the #1 life sciences cluster in the US.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Liang R Bartkowiak, MD 1701 12th Ave, Building A, Altoona, PA 16601-3100 Ph: (814) 944-7097 | Liang R Bartkowiak, MD 1701 12th Ave, Building A, Altoona, PA 16601-3100 Ph: (814) 944-7097 |
News Archive
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.
EvaluatePharma USA, Inc. the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Boston's biotech community today by Mayor Menino at the opening of their new office in Boston, the #1 life sciences cluster in the US.
› Verified 1 days ago
Sarah Schroeder, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 Howard Ave, Allegheny Family Physicians, Altoona, PA 16601 Phone: 814-889-2020 | |
Marie Ann Wetzel, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 501 Howard Ave, Suite E-3, Altoona, PA 16601 Phone: 814-946-0429 Fax: 814-946-9299 | |
Swathi Malepati, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1701 12th Ave, Altoona, PA 16601 Phone: 814-944-7097 | |
Dr. Keiko Kariya, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1414 9th Ave, Station Medical Center, Altoona, PA 16602 Phone: 814-946-1655 Fax: 814-949-7616 | |
Marina A Opida, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2918 6th Ave, Altoona, PA 16602 Phone: 814-944-6055 Fax: 814-944-1912 | |
Theodore J. Hovick Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2918 6th Ave, Altoona, PA 16602 Phone: 814-889-2626 Fax: 814-889-3197 |